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Abstract
On 3rd October 2016 a convention was held in the Aldo Moro room of the Chamber of 
Deputies on “Research on biological materials of human origin. Jurists and scientists face 
to face”. The convention was organised by the Bioethics Unit of the Istituto Superiore di 
Sanità (ISS, Italian National Institute of Health) in conjunction with the Italian Acad-
emy of the Internet Code (IAIC) and the Fondazione Centro di Iniziativa Giuridica 
Piero Calamandrei. The present contribution reports the topics discussed and the key 
conclusions reached. As a follow-up to the discussion, the scientists, jurists and institu-
tions concerned are resolved to take further steps towards the formulation of opera-
tional proposals intended to facilitate research using human biological materials within a 
framework of precise and strict regulations.
Twenty-five years ago, on 19th September 1991, on the 
Italian side of the Similaun glacier in the Alps, 92 me-
tres from the border between Austria and Italy, Erika 
and Helmut Simon found a mummified man. The man 
is now known as Ötzi, the “Man of the Similaun” or as 
the “Ice Man”. According to dating techniques, he lived 
approximately 5100 years ago. The discovery immedi-
ately sparked a debate as to the exact side of the border 
on which Ötzi had been found. He was first taken by 
helicopter to Vent, in Austria, and thence in a hearse to 
Innsbruck, were he was closely examined using several 
techniques. Claims that Ötzi had been found in Italy 
were subsequently shown to be correct and, following 
an agreement between the Austrian Government and 
the Italian district of Bolzano, the body was returned to 
Italy and housed at the South Tyrol Archaeological Mu-
seum. The ethnic origin of the mummy known as Ötzi 
has been the subject of contentious debate. He was dis-
covered in a region of modern-day Italy that belonged 
to the Austro-Hungarian empire prior to its partitioning 
in the wake of World War I. Consequently, the major-
ity of its inhabitants still feel a strong sense of Austro-
Hungarian – or more specifically, Tyrolean – identity. 
The finding that Ötzi had been wounded in the shoulder 
by an arrow led to yet further debate. Had he been walk-
ing from North to South or from South to North? Had 
he been injured by an Austro-German or by an Italian? 
Was his genetic inheritance Mediterranean or Northern 
European? And could he offer proof that South Tyro-
leans were of German stock and not Italian? In 1993 a 
group of researchers, none of whom was Italian, took 
tissue samples and analysed Ötzi’s mitochondrial DNA. 
The results were published in Science on 17th June 1994: 
“this sequence shows that the mitochondrial type of the 
Ice Man fits into the genetic variation of contemporary 
Europeans and that it was most closely related to mito-
chondrial types determined from central and northern 
European populations” [1]. On 28th February 2012 An-
dreas Keller and coauthors reported, in an article pub-
lished in Nature Communications, “the complete genome 
sequence of the Iceman”, showing “100% concordance 
between the previously reported mitochondrial genome 
sequence and the consensus sequence generated from 
our genomic data”. They reported “indications for recent 
common ancestry between the Iceman and present-day 
inhabitants of the Tyrrhenian Sea, that the Iceman prob-
ably had brown eyes, belonged to blood group O and 
was lactose intolerant. His genetic predisposition shows 
an increased risk for coronary heart disease and may 
have contributed to the development of previously re-
ported vascular calcifications” [2]. On 7th October 2012, 
Marek Janko, Robert W. Stark and Albert Zink, in the 
Journal of The Royal Society Interface, “show that RBCs 
[red blood cells] were preserved in Iceman tissue sam-
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ples for more than 5000 years. The morphological and 
molecular composition of the blood corpuscle is verified 
by atomic force microscope and Raman spectroscopy 
measurements” [3].
From an ethical perspective, these genetic tests raise 
important questions. Since Ötzi clearly could not and 
did not consent to being transferred from Italy to Aus-
tria and back or to the storage and analysis of his bio-
logical tissues, how were the ethical requirements for 
biological sample transfer and use respected? We can-
not imply consent from any significant social activity of 
his, nor can we apply the principle of proxy consent: not 
only are his descendants (in the broad biological sense) 
unknown and hotly contested, but the very purpose of 
the research is to identify them. The same circular sce-
nario occurs if we try to identify a modern-day ethnic 
or cultural group that identifies with him historically: 
both the Italians and the Austrians would include Ötzi 
in their history, leading us once more right back to the 
initial point of contention. We might think to ask what 
Ötzi himself would have wanted, but our knowledge of 
his culture is so limited and the distance between ours 
and his so vast that the question would ultimately be 
meaningless. To make matters even more nebulous, the 
research provides no direct benefits to Ötzi.
So how should we judge these studies on Ötzi in 
ethical terms? Each of us is free to answer as he or 
she thinks fit, but the majority of ethicists would most 
probably agree that they are acceptable. The problem 
is, rather, whether or not some of those studies are per-
haps a little “over the top” and of doubtful scientific 
value. This reference to the well known mummy Ötzi, 
with its mention of some of the difficulties encountered 
in reconciling the interests of scientific research, ethical 
values and legal regulations, introduced the discussions 
of the Convention on “Research on biological materi-
als of human origin. Jurists and scientists face to face” 
in the Aldo Moro room of the Chamber of Deputies. 
The Convention was organised by the Bioethics Unit 
of the Istituto Superiore di Sanità (ISS, Italian National 
Institute of Health) together with the Italian Academy 
of the Internet Code (IAIC) and the Fondazione Cen-
tro di Iniziativa Giuridica Piero Calamandrei and was 
broadcast live via the Chamber of Deputies web tv.
The authors of the present article, the Head of the 
Bioethics Unit (CP) and the President (WR) of the 
ISS, respectively opened and concluded the discus-
sions. Opening addresses were also given by repre-
sentatives of the other two institutions responsible for 
organising the Convention, namely Professor Alberto 
Gambino (President of the IAIC and Deputy Chancel-
lor of the European University of Rome) and Profes-
sor Giorgio Resta (Associate Professor of Comparative 
Private Law at the Faculty of Jurisprudence of Roma 
Tre University).
The morning session of the Convention was moder-
ated by Professor Marialuisa Lavitrano (co-Chair of 
the Management Committee of the Biobanking and 
Biomolecular Research Infrastructure – BBMRI and 
co-Director of the Common Service Ethical Legal So-
cietal Issues of the same institution), and the afternoon 
session was moderated by Professor Vincenzo Zeno-
Zencovich, full Professor of Comparative Law at Roma 
Tre University.
Other contributions were received from the Hon. 
Paola Binetti of the Chamber of Deputies Social Affairs 
Committee, and from Professor Pietro Rescigno, one of 
the most authoritative representatives of Italian juris-
prudence. In the wake of the discussion, the scientists, 
jurists and institutions concerned are resolved to move 
ahead towards the formulation of practical proposals 
to facilitate research using human biological materials 
within a framework of clear and rigorous regulations. 
This initiative is largely inspired by the considerations 
voiced in the three concluding addresses, of which the 
following paragraphs are a summary.
The final addresses followed on from the topics dis-
cussed during the day, which touched on all the stages 
through which human biological materials pass when 
they are used for research purposes, from their isola-
tion and preservation to their examination. These 
stages comprise numerous aspects: the organisation of 
biobanks (the requisites for their establishment and ac-
creditation); approval of the research projects (the re-
sponsibility of ethics committees and the Italian Data 
Protection Authority); the acquisition of biological ma-
terials (problems involving consent, management and 
communication of possible incidental findings, non-
monetary incentives, the principle of finality, research 
on material from deceased subjects); the preservation 
of biological materials (problems concerning the notion 
of “identifiability” of samples, requisites of anonymity, 
safety measures); the uses of biological materials (range 
of consent and types of permissible research, second-
ary uses of materials, patentability); the appropriation 
of samples and data (ownership conflicts between re-
searchers and patients or between researchers, legal 
protection of data banks and individual contributions of 
single research units); the transfer and sharing of data 
and samples (regulations for transfer abroad, data shar-
ing models).
The President of the ISS placed particular emphasis 
on the following aspects:
• in the field of research, aspects of ethics should re-
ceive the same consideration as scientific aspects, 
which means that a constant dialogue between ethi-
cists, researchers and jurists is indispensable; 
• there is a need for exhaustive and strict regulations, 
which should nonetheless not suffocate research efforts;
• there is also a need for financial backing by the State 
in order to ensure the viability of the system of biobanks 
for research. The situation in Italy is not encouraging, 
with unofficial figures suggesting that 85% of global 
public financing for research is accounted for by the 
US, about 5% by Japan, 4% by China, and the rest by 
Europe;
• Italy should aim to have a national research agency 
that combines funding for both research and gover-
nance;
• notwithstanding the generally unfavourable econom-
ic situation, there are signs of recovery and excitement 
in the Italian research field. Two events deserve mention 
in this respect: the re-organisation of the ISS [4] and 
the launching of Human Technopole.












The honourable Paola Binetti began her contribution 
by remarking on the great promise currently offered by 
several lines of research and recalled, in particular, inno-
vative drugs and precision medicine. She then submit-
ted the following points to the attention of participants: 
• Italy still lacks comprehensive legislation covering 
research with human biological materials and no bills 
on this topic are currently in the pipeline, though some 
aspects are addressed in various other laws;
• of particular interest to legislators – who are constant-
ly in touch with the Italian Data Protection Authority – 
is the question of informed consent: biological samples 
should be used only for the purposes specified by the 
donor. However, the need for a long-term view makes 
it difficult to establish limits to the possible uses of bio-
logical materials, and no checklist for use in assessing 
the precise nature of informed consent could ever con-
template all the possibilities. There is thus a need to 
ensure mutual trust between researchers and donors;
• the need to promote research of real quality suggests 
the usefulness of careful vetting procedures for new 
projects;
• the transparency of results is essential and implies – 
among other things – the obligation to publish negative 
as well as positive findings;
• biobanks are essential for the future development 
of biomedicine: after decades of studying the general 
features of diseases, research is now focusing more on 
individual peculiarities, so that biobanks are a valuable 
resource enabling comparisons between different indi-
viduals, as well as between samples from the same in-
dividual;
• it is therefore the duty of legislators not to obstruct, 
but rather to facilitate research, while being constantly 
on the alert for situations that could lead insidiously to 
ethically unacceptable deviations. Sectors such as the 
donation of gametes for research are particularly sensi-
tive in this sense.
Professor Pietro Rescigno recalled episodes from his 
many years of academic experience and offered some 
comments from a broad legal point of view:
• legislators should not invade the bioethics sector: it is 
to be hoped that the relevant legislation will effectively 
be directed above all to social and community educa-
tion (of professionals, patients and the general public);
• the notions of ownership, consent and non-remuner-
ation are of particular importance;
• a balance needs to be struck between the interests of 
research and the rights of the individual from whom the 
material is taken.
On the basis of these contributions the organisers 
are resolved to promote cooperation between research-
ers, jurists, ethicists and the community in general to 
formulate practicable proposals to define a legislative 
framework, the limits of informed consent, and the sus-
tainability of biobanks for research.
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